---
title: Patterns of use of symptomatic treatments for Alzheimer's disease dementia
  (AD)
date: '2023-11-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37946118/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231110170941&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Approximately two thirds of newly diagnosed AD dementia
  patients utilized approved symptomatic treatment. Time on first therapy was relatively
  short (< 1 year) and the majority did not move to a second therapy, highlighting
  the need for better adherence and persistence to existing AD symptomatic therapies
  and the need for additional therapies to alleviate the significant burden of AD
  ...'
disable_comments: true
---
CONCLUSION: Approximately two thirds of newly diagnosed AD dementia patients utilized approved symptomatic treatment. Time on first therapy was relatively short (< 1 year) and the majority did not move to a second therapy, highlighting the need for better adherence and persistence to existing AD symptomatic therapies and the need for additional therapies to alleviate the significant burden of AD ...